EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 8,420.00
-70.00 (-0.82%)
Oct 8, 2026, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 309.45 billion as of October 9, 2026. It is the 20,086th most valuable company in the world and the 649th biggest in South Korea. Its market cap has decreased by 36.23% in one year.
Market Cap
309.45B
Enterprise Value
n/a
Revenue
96.04B
Global Rank
Country Rank
#649 South Korea
PE Ratio
12.44
ChartMarket Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 309.45B, an increase of 151.88%. That is a compound annual growth rate of 9.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 309.45B | -25.72% |
| Dec 30, 2025 | 416.60B | -6.15% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ildong Pharmaceutical | 441.74B |
| HLB Pharmaceutical | 430.65B |
| Bukwang Pharmaceutical | 400.09B |
| Dong-A ST | 336.87B |
| JW Holdings | 284.03B |
| Humedix | 264.71B |
| Korea United Pharm | 255.22B |
| Samjin Pharmaceuticals | 246.38B |